The platform will undergo maintenance on Sep 14 at about 7:45 AM EST and will be unavailable for approximately 2 hours.
1990
DOI: 10.1099/0022-1317-71-1-77
|View full text |Cite
|
Sign up to set email alerts
|

Virus Neutralizing and Enhancing Epitopes Characterized by Synthetic Oligopeptides Derived from the Feline Leukaemia Virus Glycoprotein Sequence

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
11
0

Year Published

1992
1992
2012
2012

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 17 publications
(14 citation statements)
references
References 38 publications
0
11
0
Order By: Relevance
“…Functional studies of the surface glycoprotein of feline leukemia virus (FeLV) have revealed specific segments that are responsible for receptor binding (11,12), specific pathogenic properties (6), and neutralization sites (10,13,14,15). Previous reports have described a clustering of neutralization sites within a proline-rich sequence located between amino acids 230-289 of gp70 (10,13,14,15).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Functional studies of the surface glycoprotein of feline leukemia virus (FeLV) have revealed specific segments that are responsible for receptor binding (11,12), specific pathogenic properties (6), and neutralization sites (10,13,14,15). Previous reports have described a clustering of neutralization sites within a proline-rich sequence located between amino acids 230-289 of gp70 (10,13,14,15).…”
Section: Introductionmentioning
confidence: 99%
“…The alternative to complete structural determination of retroviral envelope proteins has been to dissect the structurefunction relationships of these proteins through indirect means. Retroviral envelope protein structure and function has been analyzed by using the construction of chimeric viruses (4,6), site-specific mutagenesis (3,7), and studies with small synthetic peptides and specific antibodies (8,9,10), to make inferences about specific structural and functional domains.…”
Section: Introductionmentioning
confidence: 99%
“…This leads to a marrow-origin, cellfree viraemia and further tertiary replication in mucosal sites from where it is shed in high concentrations (Francis et al, 1977). Antigenic targets for the virus are less well defined although sites involved in complementmediated lysis, antibody-dependent cellular cytotoxicity of virus-infected cells (McCarty & Grant, 1983;Grant et al, 1980a) and neutralization (Osterhaus et al, 1989;deNoronha et al, 1983;Grant et al, 1980b) have been mapped to the gp70 and pI5E envelope proteins Nunberg et al, 1984;Nick et al, 1990). Studies with analogous viruses would also suggest that both the core gag and env protein can act as important immunological targets for cytotoxic T cells (Tc) (Holt et al, 1986;van der Hoorn et al, t985;Flyer et al, 1983;Manjunath et al, 1986;Martin & Rouse, 1990).…”
Section: Discussionmentioning
confidence: 99%
“…The role which this protein plays in the pathogenesis of FeLV infection is still controversial as claims for a potent immunosuppressive effect and hence exclusion from any vaccine preparation lie side by side with arguments for its inclusion in any vaccine because anti-pl 5E antibodies could have a beneficial effect on protection (Olsen et al, 1977;Mathes et al, 1978Mathes et al, , 1979. Antibody reactivity which maps to the N-terminal end of pl 5E is capable of viral neutralization (Nick et al, 1990) and thus may play a role during the systemic phase of the infection. When we compared FHVAtkgp85 plus AcNPVgp85 with FHVAtkgp70 plus AcNPVgp70, the regime which contained p 15E gave better protection indicating that in this particular format no deleterious effect of p 15E could be detected.…”
Section: Discussionmentioning
confidence: 99%
“…Additional peptides were chosen from the beginning of the amino acid sequence of the MuLV glyco-Gag protein, a known epitope of murine sarcoma virus (MSV)-induced tumors (3,19,27,29,46,47). The Env peptides (SU and TM) were chosen from (i) known epitopes of the FeLV gp70 (52,70,71), (ii) the epitope of the broadly neutralizing XMRV Env monoclonal antibody 83A25 (39,45,50,51), (iii) epitopes of narrowly reacting nonneutralizing monoclonal antibodies, (iv) a major cytotoxic T lymphocyte (CTL) epitope in p15E (21,63), (v) studies on FeLV TM epitopes (37,44), and (vi) critical portions of the immunosuppressive domain as defined in MuLV (7,35,41) and analogous to antigenic peptides from HIV.…”
Section: Methodsmentioning
confidence: 99%